What is Zacks Research’s Forecast for Palomar Q1 Earnings?

Palomar Holdings, Inc. (NASDAQ:PLMR) – Equities research analysts at Zacks Research dropped their Q1 2027 earnings per share (EPS) estimates for Palomar in a research note issued on Friday, July 3rd. Zacks Research analyst Team now forecasts that the company will post earnings of $2.18 per share for the quarter, down from their previous estimate of $2.28. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $8.93 per share. Zacks Research also issued estimates for Palomar’s Q4 2027 earnings at $2.71 EPS, FY2027 earnings at $9.66 EPS, Q1 2028 earnings at $3.12 EPS and Q2 2028 earnings at $2.26 EPS.

Several other equities analysts have also recently weighed in on PLMR. Keefe, Bruyette & Woods decreased their price objective on Palomar from $186.00 to $159.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th. JPMorgan Chase & Co. reduced their price target on Palomar from $160.00 to $150.00 and set an “overweight” rating for the company in a research report on Tuesday, May 26th. Piper Sandler lowered their price target on Palomar from $151.00 to $132.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Finally, Weiss Ratings upgraded Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, June 18th. Four equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $147.75.

Palomar Stock Performance

Shares of PLMR opened at $145.29 on Wednesday. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31. Palomar has a 12 month low of $100.81 and a 12 month high of $147.44. The firm has a fifty day simple moving average of $116.29 and a 200 day simple moving average of $123.05. The stock has a market capitalization of $3.85 billion, a price-to-earnings ratio of 20.24 and a beta of 0.41.

Palomar (NASDAQ:PLMR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.17 by $0.14. The business had revenue of $278.94 million for the quarter, compared to analysts’ expectations of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The firm’s revenue was up 59.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.87 EPS.

Insider Activity

In related news, President Jon Christianson sold 6,863 shares of the company’s stock in a transaction dated Thursday, July 2nd. The shares were sold at an average price of $139.50, for a total value of $957,388.50. Following the transaction, the president owned 66,478 shares in the company, valued at approximately $9,273,681. This represents a 9.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Timothy Carter sold 480 shares of the firm’s stock in a transaction that occurred on Sunday, June 28th. The stock was sold at an average price of $124.29, for a total transaction of $59,659.20. Following the sale, the insider owned 1,670 shares of the company’s stock, valued at $207,564.30. This trade represents a 22.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 22,977 shares of company stock valued at $2,933,488 over the last ninety days. 3.70% of the stock is currently owned by company insiders.

Institutional Trading of Palomar

Several institutional investors have recently added to or reduced their stakes in PLMR. Geneos Wealth Management Inc. acquired a new position in Palomar in the 4th quarter valued at $32,000. Kestra Advisory Services LLC acquired a new stake in shares of Palomar during the fourth quarter worth $33,000. Rockefeller Capital Management L.P. lifted its holdings in shares of Palomar by 81.5% during the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after buying an additional 132 shares in the last quarter. Frazier Financial Advisors LLC bought a new stake in shares of Palomar in the fourth quarter valued at about $54,000. Finally, Parallel Advisors LLC boosted its position in shares of Palomar by 638.3% in the first quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after acquiring an additional 383 shares during the period. 90.25% of the stock is currently owned by institutional investors.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.